In the rapidly evolving biotechnology sector, scaling from start-up to global contender presents a myriad of challenges. These challenges are not insurmountable but rather opportunities to propel growth and establish a presence on the world stage.

As I prepare to take part in a panel discussion at this week’s IBioIC conference in Glasgow, I wanted to share my insights on the critical importance of seizing opportunities for international visibility, the strength of Scottish talent, and the lessons learned from recent endeavours.